NT-Probnp levels to perspectively assess acut cardiac failure after adjuvant doxorubicine therapy in early breast cancer patients

dc.contributor.authorCil, T.
dc.contributor.authorAltintas, A.
dc.contributor.authorPasa, S.
dc.contributor.authorKaplan, M. A.
dc.contributor.authorAlan, S.
dc.contributor.authorIsikdogan, A.
dc.date.accessioned2024-04-24T17:14:56Z
dc.date.available2024-04-24T17:14:56Z
dc.date.issued2008
dc.departmentDicle Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.doi10.1200/jco.2008.26.15_suppl.13541
dc.identifier.issn0732-183X
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/jco.2008.26.15_suppl.13541
dc.identifier.urihttps://hdl.handle.net/11468/18267
dc.identifier.volume26en_US
dc.identifier.wosWOS:000208457400627
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherAmer Soc Clinical Oncologyen_US
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keyword]en_US
dc.titleNT-Probnp levels to perspectively assess acut cardiac failure after adjuvant doxorubicine therapy in early breast cancer patientsen_US
dc.titleNT-Probnp levels to perspectively assess acut cardiac failure after adjuvant doxorubicine therapy in early breast cancer patients
dc.typeConference Objecten_US

Dosyalar